Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Anders Valind, Bronte Manouk Verhoeven, Jens Enoksson, Jenny Karlsson, Gustav Christensson, Adriana Mañas, Kristina Aaltonen, Caroline Jansson, Daniel Bexell, Ninib Baryawno, David Gisselsson & Catharina Hagerling. (2023) Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy. OncoImmunology 12:1.
Read now
Read now
Feng Zhang, Zhuo Tian, Tinghong Li, Xianjun Hu & Jin Zhu. (2021) Prognostic Value of c-MYC Expression in Patients with Peripheral Neuroblastic Tumors. International Journal of General Medicine 14, pages 2901-2907.
Read now
Read now
Chen Zheng, Shuaibin Liu, Jiexiong Feng & Xiang Zhao. (2020) Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma. Cancer Management and Research 12, pages 2415-2425.
Read now
Read now
Mikko Siurala, Markus Vähä-Koskela, Riikka Havunen, Siri Tähtinen, Simona Bramante, Suvi Parviainen, J. Michael Mathis, Anna Kanerva & Akseli Hemminki. (2016) Syngeneic Syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting. OncoImmunology 5:5.
Read now
Read now
Articles from other publishers (87)
Seiichiro Inoue, Yuta Takeuchi, Yutaka Horiuchi, Takashi Murakami & Akio Odaka. (2023) CD69 on Tumor-Infiltrating Cells Correlates With Neuroblastoma Suppression by Simultaneous PD-1 and PD-L1 Blockade. Journal of Surgical Research 289, pages 190-201.
Crossref
Crossref
Wei Bao, Zhiping Song, Hao Wan, Xiaoping Yu, Zhaoyan Chen, Yaqing Jiang, Xiao Chen & Kai Le. (2023) Model for predicting prognosis and immunotherapy based on CD+8 T cells infiltration in neuroblastoma. Journal of Cancer Research and Clinical Oncology 149:12, pages 9839-9855.
Crossref
Crossref
Ji Hyung Hong & In Sook Woo. (2023) Metronomic chemotherapy as a potential partner of immune checkpoint inhibitors for metastatic colorectal cancer treatment. Cancer Letters 565, pages 216236.
Crossref
Crossref
Irfete S. Fetahu, Wolfgang Esser-Skala, Rohit Dnyansagar, Samuel Sindelar, Fikret Rifatbegovic, Andrea Bileck, Lukas Skos, Eva Bozsaky, Daria Lazic, Lisa Shaw, Marcus Tötzl, Dora Tarlungeanu, Marie Bernkopf, Magdalena Rados, Wolfgang Weninger, Eleni M. Tomazou, Christoph Bock, Christopher Gerner, Ruth Ladenstein, Matthias Farlik, Nikolaus Fortelny & Sabine Taschner-Mandl. (2023) Single-cell transcriptomics and epigenomics unravel the role of monocytes in neuroblastoma bone marrow metastasis. Nature Communications 14:1.
Crossref
Crossref
Emily P. Vonderhaar, Michael B. Dwinell & Brian T. Craig. (2023) Targeted immune activation in pediatric solid tumors: opportunities to complement local control approaches. Frontiers in Immunology 14.
Crossref
Crossref
Gennaro Bruno, Nicoletta Nastasi, Angela Subbiani, Alessia Boaretto, Sara Ciullini Mannurita, Gianluca Mattei, Patrizia Nardini, Chiara Della Bella, Alberto Magi, Alessandro Pini, Emanuela De Marco, Annalisa Tondo, Claudio Favre & Maura Calvani. (2023) β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma. Cancer Gene Therapy 30:6, pages 890-904.
Crossref
Crossref
Zoriamin Rivera, Carlos Escutia, Mary Beth Madonna & Kajal H. Gupta. (2023) Biological Insight and Recent Advancement in the Treatment of Neuroblastoma. International Journal of Molecular Sciences 24:10, pages 8470.
Crossref
Crossref
Shifra Ash & Nadir Askenasy. (2023) Immunotherapy for neuroblastoma by hematopoietic cell transplantation and post-transplant immunomodulation. Critical Reviews in Oncology/Hematology 185, pages 103956.
Crossref
Crossref
Xin Li, Yanlong Zheng, Qiao Ge, Zhenbo Dai, Dejun Zhou & Xiangdong Tian. (2023) Integrating Bulk-seq and Single-cell-seq Reveals Estrogen and MAPK Pathways Associating with Neuroblastoma Outcome. Cancer Control 30.
Crossref
Crossref
Fereshteh Yazdanpanah & Nima Rezaei. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
18
.
Yunlong Zhang, Chenghang Zhang, Yue Ma, Changchun Li, Zhenzhen Zhao, Liang Peng, Xiaobin Deng, Jianwu Zhou & Shan Wang. (2022) Prediction to the prognosis of children with neuroblastoma by nomogram based on the first-diagnosed inflammatory markers. Pediatric Surgery International 39:1.
Crossref
Crossref
Valeria Lucarini, Ombretta Melaiu, Silvia D’Amico, Fabio Pastorino, Patrizia Tempora, Marco Scarsella, Marco Pezzullo, Adele De Ninno, Valentina D’Oria, Michele Cilli, Laura Emionite, Paola Infante, Lucia Di Marcotullio, Maria Antonietta De Ioris, Giovanni Barillari, Rita Alaggio, Luca Businaro, Mirco Ponzoni, Franco Locatelli & Doriana Fruci. (2022) Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Rasa Zafari, Sepideh Razi & Nima Rezaei. (2022) The role of dendritic cells in neuroblastoma: Implications for immunotherapy. Immunobiology 227:6, pages 152293.
Crossref
Crossref
Qingqing Liu, Zhenni Wang, Yan Jiang, Fengling Shao, Yue Ma, Mingzhao Zhu, Qing Luo, Yang Bi, Lijian Cao, Liang Peng, Jianwu Zhou, Zhenzhen Zhao, Xiaobin Deng, Tong-Chuan He & Shan Wang. (2022) Single-cell landscape analysis reveals distinct regression trajectories and novel prognostic biomarkers in primary neuroblastoma. Genes & Diseases 9:6, pages 1624-1638.
Crossref
Crossref
Roshna Lawrence Gomez, Shakhzada Ibragimova, Revathy Ramachandran, Anna Philpott & Fahad R. Ali. (2022) Tumoral heterogeneity in neuroblastoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:6, pages 188805.
Crossref
Crossref
Hongmei Du & Weisong Cai. (2022) Opsoclonus‐myoclonus syndrome associated with neuroblastoma: Insights into antitumor immunity. Pediatric Blood & Cancer 69:11.
Crossref
Crossref
Yong-Liang Sha, Yun Liu, Jia-Xing Yang, Yang-Yang Wang, Bao-Cheng Gong, Yan Jin, Tong-Yuan Qu, Fan-Tong Xia, Lei Han & Qiang Zhao. (2022) B3GALT4 remodels the tumor microenvironment through GD2-mediated lipid raft formation and the c-met/AKT/mTOR/IRF-1 axis in neuroblastoma. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Xiaojun Yuan, Janith A. Seneviratne, Shibei Du, Ying Xu, Yijun Chen, Qianya Jin, Xuanxuan Jin, Anushree Balachandran, Shihao Huang, Yanli Xu, Yue Zhai, Liumei Lu, Mengjie Tang, Yushuang Dong, Belamy B. Cheung, Glenn M. Marshall, Weiyang Shi, Daniel R. Carter & Chao Zhang. (2022) Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory. Cell Reports 41:1, pages 111455.
Crossref
Crossref
Jingjing Song, Chao Ni, Xubin Dong, Chenang Sheng, Yue Qu & Libin Zhu. (2022) bub1 as a potential oncogene and a prognostic biomarker for neuroblastoma. Frontiers in Oncology 12.
Crossref
Crossref
Bo Qiu & Katherine K. Matthay. (2022) Advancing therapy for neuroblastoma. Nature Reviews Clinical Oncology 19:8, pages 515-533.
Crossref
Crossref
Kristina Ihrmark Lundberg, Diana Treis & John Inge Johnsen. (2022) Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies. Current Oncology Reports 24:8, pages 1053-1062.
Crossref
Crossref
Marzia Ognibene, Patrizia De Marco, Stefano Parodi, Mariaclaudia Meli, Andrea Di Cataldo, Federico Zara & Annalisa Pezzolo. (2022) Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4. International Journal of Molecular Sciences 23:12, pages 6513.
Crossref
Crossref
Bronte Manouk Verhoeven, Shenglin Mei, Thale Kristin Olsen, Karin Gustafsson, Anders Valind, Axel Lindström, David Gisselsson, Shahrzad Shirazi Fard, Catharina Hagerling, Peter V. Kharchenko, Per Kogner, John Inge Johnsen & Ninib Baryawno. (2022) The immune cell atlas of human neuroblastoma. Cell Reports Medicine 3:6, pages 100657.
Crossref
Crossref
Anup S. Pathania, Philip Prathipati, Omalla A. Olwenyi, Srinivas Chava, Oghenetejiri V. Smith, Subash C. Gupta, Nagendra K. Chaturvedi, Siddappa N. Byrareddy, Don W. Coulter & Kishore B. Challagundla. (2022) miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma. Molecular Therapy - Oncolytics 25, pages 308-329.
Crossref
Crossref
Wanrong Li, Xin Li, Yuren Xia & Jian Wang. (2022) Pyroptosis-Related Gene Signature Predicts the Prognosis and Immune Infiltration in Neuroblastoma. Frontiers in Genetics 13.
Crossref
Crossref
Liang Zeng, Shu-Hua Li, Shuo-Yu Xu, Kai Chen, Liang-Jun Qin, Xiao-Yun Liu, Fang Wang, Sha Fu, Ling Deng, Feng-Hua Wang, Lei Miao, Le Li, Na Liu, Ran Wang & Hai-Yun Wang. (2022) Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology. Frontiers in Immunology 13.
Crossref
Crossref
Ombretta Melaiu, Valeria Lucarini, Roberto Giovannoni, Doriana Fruci & Federica Gemignani. (2022) News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors. Seminars in Cancer Biology 79, pages 18-43.
Crossref
Crossref
Yongliang Sha, Lei Han, Bei Sun & Qiang Zhao. (2022) Identification of a Glycosyltransferase Signature for Predicting Prognosis and Immune Microenvironment in Neuroblastoma. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Etienne C. Gozlan, Boris I. Chobrutskiy, Saif Zaman, Michelle Yeagley & George Blanck. (2021) Systemic Adaptive Immune Parameters Associated with Neuroblastoma Outcomes: the Significance of Gamma-Delta T Cells. Journal of Molecular Neuroscience 71:11, pages 2393-2404.
Crossref
Crossref
Wenjuan Kang, Jiajian Hu, Qiang Zhao & Fengju Song. (2021) Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Nicole Bussola, Bruno Papa, Ombretta Melaiu, Aurora Castellano, Doriana Fruci & Giuseppe Jurman. (2021) Quantification of the Immune Content in Neuroblastoma: Deep Learning and Topological Data Analysis in Digital Pathology. International Journal of Molecular Sciences 22:16, pages 8804.
Crossref
Crossref
Andrea Pelosi, Piera Filomena Fiore, Sabina Di Matteo, Irene Veneziani, Ignazio Caruana, Stefan Ebert, Enrico Munari, Lorenzo Moretta, Enrico Maggi & Bruno Azzarone. (2021) Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms’ Tumors. Cancers 13:10, pages 2374.
Crossref
Crossref
Claudia Cocco, Fabio Morandi & Irma Airoldi. (2021) Immune Checkpoints in Pediatric Solid Tumors: Targetable Pathways for Advanced Therapeutic Purposes. Cells 10:4, pages 927.
Crossref
Crossref
Teresa Krabbe, Janina Marek, Tanja Groll, Katja Steiger, Roland M. Schmid, Angela M. Krackhardt & Jennifer Altomonte. (2021) Adoptive T Cell Therapy Is Complemented by Oncolytic Virotherapy with Fusogenic VSV-NDV in Combination Treatment of Murine Melanoma. Cancers 13:5, pages 1044.
Crossref
Crossref
Salvatore Raieli, Daniele Di Renzo, Silvia Lampis, Camilla Amadesi, Luca Montemurro, Andrea Pession, Patrizia Hrelia, Matthias Fischer & Roberto Tonelli. (2021) MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma. Frontiers in Oncology 11.
Crossref
Crossref
Yu-Mei Liao, Tsai-Hsien Hung, John K. Tung, John Yu, Ya-Ling Hsu, Jung-Tung Hung & Alice L. Yu. (2021) Low Expression of IL-15 and NKT in Tumor Microenvironment Predicts Poor Outcome of MYCN-Non-Amplified Neuroblastoma. Journal of Personalized Medicine 11:2, pages 122.
Crossref
Crossref
Giulia Vanoni, Giuseppe Ercolano, Simona Candiani, Mariangela Rutigliani, Mariangela Lanata, Laurent Derré, Emanuela Marcenaro, Pascal Schneider, Pedro Romero, Camilla Jandus & Sara Trabanelli. (2021) Human primed ILCPs support endothelial activation through NF-κB signaling. eLife 10.
Crossref
Crossref
Judith Wienke, Miranda P. Dierselhuis, Godelieve A.M. Tytgat, Annette Künkele, Stefan Nierkens & Jan J. Molenaar. (2021) The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology. European Journal of Cancer 144, pages 123-150.
Crossref
Crossref
Valeria Lucarini, Ombretta Melaiu, Patrizia Tempora, Silvia D’Amico, Franco Locatelli & Doriana Fruci. (2021) Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment. Cancers 13:3, pages 433.
Crossref
Crossref
Sai Batchu. (2021) Immunological landscape of Neuroblastoma and its clinical significance. Cancer Treatment and Research Communications 26, pages 100274.
Crossref
Crossref
Wenyi Jin, Yubiao Zhang, Zilin Liu, Zhifei Che, Mingyong Gao & Hao Peng. (2020) Exploration of the molecular characteristics of the tumor–immune interaction and the development of an individualized immune prognostic signature for neuroblastoma. Journal of Cellular Physiology 236:1, pages 294-308.
Crossref
Crossref
Piamsiri Sawaisorn, Korakot Atjanasuppat, Usanarat Anurathapan, Somchai Chutipongtanate & Suradej Hongeng. (2020) Strategies to Improve Chimeric Antigen Receptor Therapies for Neuroblastoma. Vaccines 8:4, pages 753.
Crossref
Crossref
Victoria Klepsch, Maria Pommermayr, Dominik Humer, Natascha Brigo, Natascha Hermann-Kleiter & Gottfried Baier. (2020) Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy. Cell Communication and Signaling 18:1.
Crossref
Crossref
Farzaneh Jafari, Saeed Javdansirat, Sarvin Sanaie, Amirreza Naseri, Ali Shamekh, Davood Rostamzadeh & Sanam Dolati. (2020) Osteosarcoma: A comprehensive review of management and treatment strategies. Annals of Diagnostic Pathology 49, pages 151654.
Crossref
Crossref
Ombretta Melaiu, Marco Chierici, Valeria Lucarini, Giuseppe Jurman, Libenzio Adrian Conti, Rita De Vito, Renata Boldrini, Loredana Cifaldi, Aurora Castellano, Cesare Furlanello, Vincenzo Barnaba, Franco Locatelli & Doriana Fruci. (2020) Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma. Nature Communications 11:1.
Crossref
Crossref
Chao Xin, Jianmin Zhu, Song Gu, Minzhi Yin, Jing Ma, Ci Pan, Jingyan Tang, Peng Zhang, Yang Liu, Xue-Feng Bai, Xi Mo, Min Xu & Hua Zhu. (2020) CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment. Cancer Immunology, Immunotherapy 69:11, pages 2333-2343.
Crossref
Crossref
Laurence Blavier, Ren-Ming Yang & Yves A. DeClerck. (2020) The Tumor Microenvironment in Neuroblastoma: New Players, New Mechanisms of Interaction and New Perspectives. Cancers 12:10, pages 2912.
Crossref
Crossref
Emily R. Webb, Silvia Lanati, Carol Wareham, Alistair Easton, Stuart N. Dunn, Tatyana Inzhelevskaya, Freja M. Sadler, Sonya James, Margaret Ashton-Key, Mark S. Cragg, Stephen A. Beers & Juliet C. Gray. (2020) Immune characterization of pre-clinical murine models of neuroblastoma. Scientific Reports 10:1.
Crossref
Crossref
Kevin X. Liu & Shweta Joshi. (2020) “Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma. Frontiers in Immunology 11.
Crossref
Crossref
Seiichiro Inoue, Yutaka Horiuchi, Yumiko Setoyama, Yuta Takeuchi, Yoshifumi Beck, Takashi Murakami & Akio Odaka. (2020) Immune Checkpoint Inhibition Followed by Tumor Infiltration of Dendritic Cells in Murine Neuro-2a Neuroblastoma. Journal of Surgical Research 253, pages 201-213.
Crossref
Crossref
Nadine Lehmann, Claudia Paret, Khalifa El Malki, Alexandra Russo, Marie Astrid Neu, Arthur Wingerter, Larissa Seidmann, Sebastian Foersch, Nicole Ziegler, Lea Roth, Nora Backes, Roger Sandhoff & Joerg Faber. (2020) Tumor Lipids of Pediatric Papillary Renal Cell Carcinoma Stimulate Unconventional T Cells. Frontiers in Immunology 11.
Crossref
Crossref
Davide Cangelosi, Martina Morini, Nicolò Zanardi, Angela Rita Sementa, Marco Muselli, Massimo Conte, Alberto Garaventa, Ulrich Pfeffer, Maria Carla Bosco, Luigi Varesio & Alessandra Eva. (2020) Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming. Cancers 12:9, pages 2343.
Crossref
Crossref
Shweta Joshi. (2020) Targeting the Tumor Microenvironment in Neuroblastoma: Recent Advances and Future Directions. Cancers 12:8, pages 2057.
Crossref
Crossref
Annelisa M. Cornel, Iris L. Mimpen & Stefan Nierkens. (2020) MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy. Cancers 12:7, pages 1760.
Crossref
Crossref
Rachael L. Terry, Deborah Meyran, David S. Ziegler, Michelle Haber, Paul G. Ekert, Joseph A. Trapani & Paul J. Neeson. (2020) Immune profiling of pediatric solid tumors. Journal of Clinical Investigation 130:7, pages 3391-3402.
Crossref
Crossref
Jeong A. Park & Nai-Kong V. Cheung. (2020) Targets and Antibody Formats for Immunotherapy of Neuroblastoma. Journal of Clinical Oncology 38:16, pages 1836-1848.
Crossref
Crossref
Lihong Wang-Bishop, Mohamed Wehbe, Daniel Shae, Jamaal James, Benjamin C. Hacker, Kyle Garland, Plamen P. Chistov, Marjan Rafat, Justin M. Balko & John T. Wilson. (2020) Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma. Journal for ImmunoTherapy of Cancer 8:1, pages e000282.
Crossref
Crossref
Andrew D.J. Pearson, Claudia Rossig, Giovanni Lesa, Scott J. Diede, Susan Weiner, John Anderson, Juliet Gray, Birgit Geoerger, Veronique Minard-Colin, Lynley V. Marshall, Malcolm Smith, Paul Sondel, Marcis Bajars, Claudia Baldazzi, Elly Barry, Sam Blackman, Patricia Blanc, Renaud Capdeville, Hubert Caron, Peter D. Cole, Jorge Camarero Jiménez, Pierre Demolis, Martha Donoghue, Mabrouck Elgadi, Thomas Gajewski, Sara Galluzzo, Robert IlariaJr.Jr., Alessandro Jenkner, Dominik Karres, Mark Kieran, Franca Ligas, Israel Lowy, Michael Meyers, Corina Oprea, Vijay G.R. Peddareddigari, Jaroslav Sterba, Paul K. Stockman, Peter Suenaert, Uri Tabori, Cornelis van Tilburg, Todd Yancey, Brenda Weigel, Koenraad Norga, Gregory Reaman & Gilles Vassal. (2020) ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients. European Journal of Cancer 127, pages 52-66.
Crossref
Crossref
Celina L. Szanto, Annelisa M. Cornel, Saskia V. Vijver & Stefan Nierkens. (2020) Monitoring Immune Responses in Neuroblastoma Patients during Therapy. Cancers 12:2, pages 519.
Crossref
Crossref
Shogo Zuo, Masayuki Sho, Toshio Sawai, Hiromichi Kanehiro, Kosaku Maeda, Makiko Yoshida, Ryo Tsukada, Motonari Nomura & Hiroomi Okuyama. (2020) Potential role of the PD-L1 expression and tumor-infiltrating lymphocytes on neuroblastoma. Pediatric Surgery International 36:2, pages 137-143.
Crossref
Crossref
Devendra Kumar Yadav, Vishesh Jain, Amit Kumar Dinda & Sandeep Agarwala. (2021) Tumor-Infiltrating Lymphocytes in Wilms Tumor. Indian Journal of Medical and Paediatric Oncology 41:01, pages 34-38.
Crossref
Crossref
Xiaodan Zhong, Yutong Zhang, Linyu Wang, Hao Zhang, Haiming Liu & Yuanning Liu. (2019) Cellular components in tumor microenvironment of neuroblastoma and the prognostic value. PeerJ 7, pages e8017.
Crossref
Crossref
Cari, De Rosa, Petrillo, Migliorati, Nocentini & Riccardi. (2019) Identification of 15 T Cell Restricted Genes Evaluates T Cell Infiltration of Human Healthy Tissues and Cancers and Shows Prognostic and Predictive Potential. International Journal of Molecular Sciences 20:20, pages 5242.
Crossref
Crossref
Marina Ollé Hurtado, Jolien Wolbert, Jonathan Fisher, Barry Flutter, Sian Stafford, Jack Barton, Neha Jain, Giuseppe Barone, Yvonne Majani & John Anderson. (2019) Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function. PLOS ONE 14:8, pages e0216373.
Crossref
Crossref
Meng-Xin Tian, Yu-Fu Zhou, Wei-Feng Qu, Wei-Ren Liu, Lei Jin, Xi-Fei Jiang, Han Wang, Chen-Yang Tao, Pei-Yun Zhou, Yuan Fang, Zhen-Bin Ding, Yuan-Fei Peng, Jian Zhou, Jia Fan & Ying-Hong Shi. (2019) Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomy. Cancer Immunology, Immunotherapy 68:8, pages 1369-1378.
Crossref
Crossref
Jakob Nikolas Kather, Christian Hörner, Cleo-Aron Weis, Thiha Aung, Christian Vokuhl, Christel Weiss, Monika Scheer, Alexander Marx & Katja Simon-Keller. (2019) CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma. Scientific Reports 9:1.
Crossref
Crossref
Parnian Jabbari, Sara Hanaei & Nima Rezaei. (2019) State of the art in immunotherapy of neuroblastoma. Immunotherapy 11:9, pages 831-850.
Crossref
Crossref
Daniel A. Morgenstern, Rochelle Bagatell, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Lucas Moreno, Julie R. Park, Andrew D. Pearson, Gudrun Schleiermacher, Dominique Valteau-Couanet, Wendy B. London & Meredith S. Irwin. (2019) The challenge of defining “ultra-high-risk” neuroblastoma. Pediatric Blood & Cancer 66:4, pages e27556.
Crossref
Crossref
Andrea Bizzego, Nicole Bussola, Marco Chierici, Valerio Maggio, Margherita Francescatto, Luca Cima, Marco Cristoforetti, Giuseppe Jurman & Cesare Furlanello. (2019) Evaluating reproducibility of AI algorithms in digital pathology with DAPPER. PLOS Computational Biology 15:3, pages e1006269.
Crossref
Crossref
Giuseppe Jurman, Michele Filosi, Roberto Visintainer, Samantha Riccadonna & Cesare Furlanello. 2019. Gene Regulatory Networks. Gene Regulatory Networks
323
346
.
Chiara Camisaschi, Salvatore Lorenzo Renne, Valeria Beretta, Francesca Rini, Rosalin Dolores Spagnuolo, Alessandra Tuccitto, Marta Giorgia Podda, Giorgio Parmiani, Licia Rivoltini, Paola Collini, Chiara Castelli & Roberto Luksch. (2018) Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients. BMC Cancer 18:1.
Crossref
Crossref
Mary Frances Wedekind, Kellie B. Haworth, Michael Arnold, Joseph R. Stanek, Dean Lee & Timothy P. Cripe. (2018) Immune profiles of desmoplastic small round cell tumor and synovial sarcoma suggest different immunotherapeutic susceptibility upfront compared to relapse specimens. Pediatric Blood & Cancer 65:11, pages e27313.
Crossref
Crossref
Rebecca M. Richards, Elena Sotillo & Robbie G. Majzner. (2018) CAR T Cell Therapy for Neuroblastoma. Frontiers in Immunology 9.
Crossref
Crossref
Palanisamy Nallasamy, Srinivas Chava, Sumit S. Verma, Shruti Mishra, Santhi Gorantla, Don W. Coulter, Siddappa N. Byrareddy, Surinder K. Batra, Subash C. Gupta & Kishore B. Challagundla. (2018) PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective. Seminars in Cancer Biology 52, pages 53-65.
Crossref
Crossref
Mary Frances Wedekind, Nicholas L. Denton, Chun-Yu Chen & Timothy P. Cripe. (2018) Pediatric Cancer Immunotherapy: Opportunities and Challenges. Pediatric Drugs 20:5, pages 395-408.
Crossref
Crossref
Stephanie C. Casey, Virginie Baylot & Dean W. Felsher. (2018) The MYC oncogene is a global regulator of the immune response. Blood 131:18, pages 2007-2015.
Crossref
Crossref
Victoria Klepsch, Natascha Hermann-Kleiter, Patricia Do-Dinh, Bojana Jakic, Anne Offermann, Mirjana Efremova, Sieghart Sopper, Dietmar Rieder, Anne Krogsdam, Gabriele Gamerith, Sven Perner, Alexandar Tzankov, Zlatko Trajanoski, Dominik Wolf & Gottfried Baier. (2018) Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade. Nature Communications 9:1.
Crossref
Crossref
Si-Pei Wu, Ri-Qiang Liao, Hai-Yan Tu, Wen-Jun Wang, Zhong-Yi Dong, Shu-Mei Huang, Wei-Bang Guo, Lan-Ying Gou, Hui-Wen Sun, Qi Zhang, Zhi Xie, Li-Xu Yan, Jian Su, Jin-Ji Yang, Wen-Zhao Zhong, Xu-Chao Zhang & Yi-Long Wu. (2018) Stromal PD-L1–Positive Regulatory T cells and PD-1–Positive CD8-Positive T cells Define the Response of Different Subsets of Non–Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy. Journal of Thoracic Oncology 13:4, pages 521-532.
Crossref
Crossref
Tomoro Hishiki, Naoko Mise, Kazuaki Harada, Fumie Ihara, Mariko Takami, Takeshi Saito, Keita Terui, Mitsuyuki Nakata, Shugo Komatsu, Hideo Yoshida & Shinichiro Motohashi. (2017) Invariant natural killer T infiltration in neuroblastoma with favorable outcome. Pediatric Surgery International 34:2, pages 195-201.
Crossref
Crossref
Mahtab Rahbar, Mitra Mehrazma & Mersedeh Karimian. (2018) Tumor infiltrating cytotoxic CD8 T-Cells predict clinical outcome of neuroblastoma in children. Indian Journal of Medical and Paediatric Oncology 39:2, pages 159.
Crossref
Crossref
Thitinee Vanichapol, Somchai Chutipongtanate, Usanarat Anurathapan & Suradej Hongeng. (2018) Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma. BioMed Research International 2018, pages 1-11.
Crossref
Crossref
Véronique Minard-Colin. 2018. Immunotherapy for Pediatric Malignancies. Immunotherapy for Pediatric Malignancies
141
160
.
Peng Zhang, Xiaofang Wu, Moushumi Basu, Chen Dong, Pan Zheng, Yang Liu & Anthony David Sandler. (2017) MYCN Amplification Is Associated with Repressed Cellular Immunity in Neuroblastoma: An In Silico Immunological Analysis of TARGET Database. Frontiers in Immunology 8.
Crossref
Crossref
Ombretta Melaiu, Marco Mina, Marco Chierici, Renata Boldrini, Giuseppe Jurman, Paolo Romania, Valerio D'Alicandro, Maria C. Benedetti, Aurora Castellano, Tao Liu, Cesare Furlanello, Franco Locatelli & Doriana Fruci. (2017) PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. Clinical Cancer Research 23:15, pages 4462-4472.
Crossref
Crossref
Zhan Wang, Binghao Li, Yingqing Ren & Zhaoming Ye. (2016) T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities. Frontiers in Immunology 7.
Crossref
Crossref
Giuseppe Jurman. (2016) Metric projection for dynamic multiplex networks. Heliyon 2:8, pages e00136.
Crossref
Crossref
Giuseppe Jurman, Michele Filosi, Samantha Riccadonna, Roberto Visintainer & Cesare Furlanello. 2016. Dynamics of Mathematical Models in Biology. Dynamics of Mathematical Models in Biology
17
30
.